In the absence of clear regulatory standards, oversight is increasingly being defined through audits, investigations, and enforcement actions by federal regulators and state medical boards rather than prospective guidance.
Eric M Creizman
Advertisement
Articles by Eric M Creizman
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Nimbus Therapeutics and Eli Lilly Enter $1.3 Billion License Agreement and Research Collaboration for Oral Obesity Treatments
2
Amgen Acquires Dark Blue Therapeutics in $840 Million Transaction
3
The Real Value Equation: How Humans and AI Create and Destroy Value in Pharma
4
Novo Nordisk’s Wegovy Pill Becomes First Oral GLP-1 Available in U.S.
5